# Iptacopan in IgA Nephropathy — Final 24-Month Data

Source: [nejm.org](https://www.nejm.org/doi/full/10.1056/NEJMc2611338?af=R&rss=currentIssue) · 2026-11-11 · Medicine
Page: https://themorning.science/story/iptacopan-in-iga-nephropathy-final-24-month-data-49d25a737e79c8b8
Kind: research · Impact: low

## In brief

- The New England Journal of Medicine published a correspondence titled "Iptacopan in IgA Nephropathy — Final 24-Month Data".
- The item appears in Volume 395, Issue 19, pages 1968–1970, with an issue date of November 12, 2026.
- The source text provided contains only the title and citation, so the trial results are not reported here.

## Why it matters

It reports final 24-month data on iptacopan in IgA nephropathy, a chronic kidney disease, which is relevant to kidney researchers and clinicians following this treatment.

## Timeline

- 2026-11-11: Published on nejm.org
- 2026-11-12: Issue date: Volume 395, Issue 19, pages 1968–1970

## Coverage

- [Iptacopan in IgA Nephropathy — Final 24-Month Data](https://www.nejm.org/doi/full/10.1056/NEJMc2611338?af=R&rss=currentIssue) — nejm.org, 2026-11-11

Tags: iptacopan, iga nephropathy, kidney disease, clinical trial, nejm

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science